SHORT MINI FUTURE WARRANT - AMGEN | Real-time BOERSE MUENCHEN 11:25:48 29/05/2024 BST | ||
| 9.18 EUR | 0.00% |
|
| Current month | -22.47% | ||
| 1 month | -24.26% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 29/05/24 | 9.18 | 0.00% |
| 28/05/24 | 9.18 | +9.29% |
| 27/05/24 | 8.4 | -1.29% |
| 24/05/24 | 8.51 | +1.79% |
| 23/05/24 | 8.36 | +4.76% |
Real-time BOERSE MUENCHEN
Last update May 29, 2024 at 11:25 am
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | Goldman Sachs |
| WKN | GK8UNJ |
| ISIN | DE000GK8UNJ4 |
| Date issued | 08/08/2022 |
| Strike | 398.5 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 16.14 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 19.16 € |
|---|---|
| Lowest since issue | 7.12 € |
| Spread | 0.07 € |
| Spread % | 0.76% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
300.2
USD
Average target price
316.3
USD
Spread / Average Target
+5.36%
- Stock Market
- Certificates
- Certificat
